Sun Pharma's net profit for the quarter increased 176% to Rs 162.96 crore compared to the same period last year, while net sales declined slightly by 0.59%. The improved net profit margin was 20.99% versus 7.56% in the previous year. Equity capital increased 100% to Rs 2071.20 million for the quarter. The company's stock price at the BSE closed up 3.37% at Rs 607.40.